Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Respiratory Syncytial Virus Infections × remdesivir × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Respiratory Syncytial Virus Infections 1 Lymphoma, Follicular 1 COVID-19 1 Autoimmune Diseases 1

Interventions

remdesivir 1 Suspensions 1 Specimen Handling 1 Ribavirin 1 Injections 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06817889 2026-02-27

Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised Individuals

Fred Hutchinson Cancer Center

Phase 2 Recruiting

Autoimmune Diseases, Respiratory Syncytial Virus Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡